Monashee Investment Management LLC Athira Pharma, Inc. Transaction History

Monashee Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.74 - $13.43 $274,000 - $1.34 Million	-100,000 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$8.96 - $13.51 $896,000 - $1.35 Million	100,000 New	100,000 $1.35 Million
Q4 2020 Feb 11, 2021	SELL	$16.48 - $34.3 $1.65 Million - $3.43 Million	-100,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$16.02 - $18.46 $1.6 Million - $1.85 Million	100,000 New	100,000 $1.85 Million

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $23.4M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.